A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Nov 2013

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Bipolar disorders; Generalised anxiety disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2012 Actual patient number (49) added as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Actual end date (1 Oct 2011) added as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top